GlassScriptPhysician profile
Roberto A Leon Ferre
NPI 1427361377
$28,193.91
in general payments reported to CMS, 2019-2025
6 companies · $6,843 in 2025
The $6,843 reported for 2025 was more than what 77% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,110 · 2022: $2,432 · 2023: $7,148 · 2024: $5,661 · 2025: $6,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $710 · Education: $17.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,925.00 |
| Food and Beverage | $709.73 |
| Education | $17.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $17,291.69 | 2021-2025 | Trodelvy |
| Astrazeneca Pharmaceuticals LP | $8,767.22 | 2021-2025 | Datroway, Imfinzi |
| Merck Sharp & Dohme LLC | $2,135.00 | 2024 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Leon Ferre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.